Asia's Cancer Markets
As Asian economies boom, Western lifestyles and industrialization are causing a rise in cancer--an permitting once-poor medical systems to pay for treatment. For US companies, the trick is to follow treatment patterns and reimbursement practices which differ from country to country in the region.
You may also be interested in...
Effective medical device regulation supports both safety and innovation needs. This article assesses how well the US FDA and the Australian TGA achieve this balance.
GSK achieved a first-in-class market oncology launch in 2020, but will have to increase that hit rate in order to fulfil its blockbuster ambitions.